Scott Kathleen D.
Insider CIK 1794284 · CNAT Director · SPRY Chief Financial Officer · NKGN Director · DRMA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRMA Dermata Therapeutics, Inc. | S Sale | 2026-06-16 | 2026-06-16 | 11 | $1.19 | $13 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 2,500 | — | $0 | 2,500 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-08-21 | 2025-08-22 | 12,500 | — | $0 | 739,830 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-08-21 | 2025-08-22 | 12,500 | $15.00 | $187.5K | 10,042 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-08-21 | 2025-08-22 | 12,500 | $1.50 | $18.8K | 22,542 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-05-20 | 2025-05-22 | 50,000 | — | $0 | 752,330 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-05-20 | 2025-05-22 | 50,000 | $14.10 | $705.0K | 7,424 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-05-20 | 2025-05-22 | 50,000 | $1.50 | $75.0K | 57,424 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-01-13 | 2025-01-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 176,700 | — | $0 | 176,700 | SEC↗ |
| NKGN NKGen Biotech, Inc. | A Award deriv | 2024-12-06 | 2024-12-10 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NKGN NKGen Biotech, Inc. | A Award deriv | 2024-12-06 | 2024-12-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-17 | 12,500 | — | $0 | 802,330 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-10-16 | 2024-10-17 | 12,500 | $1.50 | $18.8K | 17,449 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-10-16 | 2024-10-17 | 12,500 | $16.00 | $200.0K | 4,949 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-08-20 | 2024-08-21 | 12,500 | — | $0 | 814,830 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 12,500 | $16.00 | $200.0K | 13,199 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-08-20 | 2024-08-21 | 12,500 | $1.50 | $18.8K | 25,699 | SEC↗ |
| NKGN NKGen Biotech, Inc. | A Award deriv | 2024-02-12 | 2024-02-14 | 300,000 | — | $0 | 300,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | P Buy | 2022-11-29 | 2022-12-01 | 8,250 | $6.24 | $51.5K | 8,250 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 827,330 | — | $0 | 827,330 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-10-06 | 2022-10-07 | 11,359 | — | $0 | 27,145 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-07-07 | 2022-07-08 | 9,960 | — | $0 | 15,786 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-04-07 | 2022-04-08 | 5,826 | — | $0 | 5,826 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2021-08-17 | 2021-08-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-11-18 | 2019-11-19 | 30,000 | — | $0 | 30,000 | SEC↗ |